GRFSGrifols SA

Nasdaq grifols.com


$ 6.38 $ 0.11 (1.75 %)    

Friday, 26-Apr-2024 15:59:56 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 6.38
$ 6.28
$ 0.00 x 0
$ 0.00 x 0
$ 6.28 - $ 6.50
$ 5.30 - $ 12.15
673,447
na
4.39B
$ 0.84
$ 13.13
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 grifols-achieves-results-from-phase-4-study-of-fanhdi-in-patients-with-von-willebrand-disease

https://www.grifols.com/en/view-news/-/news/grifols-achieves-positive-results-from-phase-4-study-of-fanhdi-double-inactivated-h...

 carmax-reports-downbeat-earnings-joins-lovesac-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday.

 grifols-achieves-milestone-in-transfusion-medicine-with-ce-mark-for-procleix-arboplex-assay

Grifols' in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of transfusion-transmitt...

 why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

 lululemon-issues-weak-outlook-joins-nike-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures gaining by around 0.1% on Friday.

 spanish-stock-market-supervisor-cnmv-says-there-were-also-deficiencies-in-the-presentation-of-alternative-performance-measures-in-particular-ebitda-and-debtebitda-ratio-cnmv-sees-no-need-for-grifols-to-restate-accounts-says-at-present-its-not-possible-to-prejudge-potential-consequences-of-any-sanctions-for-grifols

- Reuters

 spanish-stock-market-supervisor-cnmv-says-however-we-have-found-deficiencies-in-detail-accuracy-of-breakdowns-explanatory-notes-in-some-years-of-the-period-analyzed

- Reuters

 spanish-stock-market-supervisor-cnmv-says-investigations-not-identified-significant-errors-in-quantitative-magnitudes-of-grifols-main-financial-statements-for-the-period-analyzed-have-not-found-evidence-that-the-financial-debt-reported-by-grifols-does-not-correspond-to-reality

- Reuters

 grifols-gets-downgraded-fitch-sp-flag-cash-flow-concerns-at-pharma-company

Fitch and S&P downgraded Grifols' ratings due to weak free cash flow and refinancing risks.

 grifols-expects-to-address-our-2025-maturities-efficiently-in-the-first-half-of-2024-considering-the-sraas-disposal-proceeds-and-other-available-options-executing-these-commitments-will-help-grifols-achieve-leverage-levels-that-should-serve-as-basis-for-an-improvement-on-credit-rating-agencies-scorecards

- Reuters

 deutsche-bank-downgrades-grifols-to-sell

Deutsche Bank analyst Emmanuel Papadakis downgrades Grifols (NASDAQ:GRFS) from Hold to Sell.

 why-marvell-technology-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quart...

 crude-oil-falls-over-1-willdan-group-shares-spike-higher

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 80 points on Friday. The Dow traded u...

 smith--wesson-brands-reports-upbeat-earnings-joins-americas-car-mart-hci-group-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday.

Core News & Articles
Market-Moving News for March 8th
03/08/2024 13:44:29

WLDN: 21% | Willdan Group shares are trading higher after the company reported better-than-expected Q4 financial results and is...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION